搜索临床试验以:DK210(EGFR)
总计1517个结果
-
Suzhou Puhe Pharmaceutical Technology Co., LTD尚未招聘
-
HUYABIO International, LLC.招聘中
-
Tian XieLinkDoc Technology (Beijing) Co. Ltd.主动,不招人
-
Hoosier Cancer Research NetworkNovartis Pharmaceuticals; Walther Cancer Institute终止
-
Guangdong Association of Clinical TrialsJiangsu Hansoh Pharmaceutical Co., Ltd.招聘中
-
IRCCS Azienda Ospedaliera Universitaria San Martino...未知
-
Spanish Lung Cancer GroupMerck Sharp & Dohme LLC终止
-
Amsterdam UMC, location VUmc招聘中
-
Sichuan Kelun Pharmaceutical Research Institute...招聘中
-
China Medical University, ChinaGeneral Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor Hospital & Institute 和其他合作者未知
-
Massachusetts General HospitalM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Dana-Farber Cancer Institute完全的
-
Sun Yat-sen University招聘中非小细胞肺癌 (NSCLC) | EGFR-TKI 耐药突变 | EGFR-TKI致敏突变 | 体细胞突变 | 种系突变中国
-
The First Affiliated Hospital of Henan University...尚未招聘
-
National Cancer Centre, SingaporeSingapore Translational Cancer Consortium; Genome Institute of Singapore; Cancer Science Institute...招聘中
-
Shanghai Chest Hospital未知
-
Hunan Province Tumor Hospital尚未招聘
-
Hunan Province Tumor Hospital尚未招聘
-
First People's Hospital of Hangzhou尚未招聘
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZeneca主动,不招人非小细胞肺癌转移爱尔兰, 新加坡, 西班牙, 瑞士, 大韩民国, 荷兰
-
Guangdong Association of Clinical TrialsGuangdong Provincial People's Hospital招聘中
-
British Columbia Cancer AgencySunnybrook Health Sciences Centre; AstraZeneca; Princess Margaret Hospital, Canada招聘中
-
David M. Jackman, MDBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital完全的
-
ArriVent BioPharma, Inc.招聘中晚期非小细胞肺癌 | 转移性非小细胞肺癌 | 非小细胞肺癌 (NSCLC) | HER2 外显子 20 突变 | EGFR 外显子 20 突变 | EGFR 罕见突变,包括 G719X 和 S768I美国, 澳大利亚, 西班牙, 英国, 法国, 中国, 大韩民国, 加拿大, 日本, 荷兰, 意大利
-
Sichuan Kelun Pharmaceutical Research Institute...307 Hospital of PLA未知